Neoadjuvant Therapies Clinical Trials

7 clinical trials for Neoadjuvant Therapies across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Randomized, Phase II Trial — RECRUITING · PHASE2
• Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial — RECRUITING · PHASE2
• Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer — RECRUITING · PHASE2
• Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II) — RECRUITING · PHASE2
• Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I) — RECRUITING · PHASE2
• Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study — OTHER

Refine this search